RU2017104621A3 - - Google Patents

Download PDF

Info

Publication number
RU2017104621A3
RU2017104621A3 RU2017104621A RU2017104621A RU2017104621A3 RU 2017104621 A3 RU2017104621 A3 RU 2017104621A3 RU 2017104621 A RU2017104621 A RU 2017104621A RU 2017104621 A RU2017104621 A RU 2017104621A RU 2017104621 A3 RU2017104621 A3 RU 2017104621A3
Authority
RU
Russia
Application number
RU2017104621A
Other languages
Russian (ru)
Other versions
RU2017104621A (ru
RU2728867C2 (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2017104621A publication Critical patent/RU2017104621A/ru
Publication of RU2017104621A3 publication Critical patent/RU2017104621A3/ru
Application granted granted Critical
Publication of RU2728867C2 publication Critical patent/RU2728867C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2017104621A 2011-04-20 2012-04-20 Способ совместного кондиционирования и хемоселекции за один цикл RU2728867C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161477440P 2011-04-20 2011-04-20
US61/477,440 2011-04-20

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
RU2013151632A Division RU2611396C2 (ru) 2011-04-20 2012-04-20 Способ совместного кондиционирования и хемоселекции за один цикл

Publications (3)

Publication Number Publication Date
RU2017104621A RU2017104621A (ru) 2018-08-15
RU2017104621A3 true RU2017104621A3 (cg-RX-API-DMAC7.html) 2020-06-04
RU2728867C2 RU2728867C2 (ru) 2020-07-31

Family

ID=47041955

Family Applications (2)

Application Number Title Priority Date Filing Date
RU2013151632A RU2611396C2 (ru) 2011-04-20 2012-04-20 Способ совместного кондиционирования и хемоселекции за один цикл
RU2017104621A RU2728867C2 (ru) 2011-04-20 2012-04-20 Способ совместного кондиционирования и хемоселекции за один цикл

Family Applications Before (1)

Application Number Title Priority Date Filing Date
RU2013151632A RU2611396C2 (ru) 2011-04-20 2012-04-20 Способ совместного кондиционирования и хемоселекции за один цикл

Country Status (11)

Country Link
US (1) US9439928B2 (cg-RX-API-DMAC7.html)
EP (3) EP2699247B1 (cg-RX-API-DMAC7.html)
JP (4) JP5997257B2 (cg-RX-API-DMAC7.html)
AU (3) AU2012245269B2 (cg-RX-API-DMAC7.html)
CA (1) CA2861440C (cg-RX-API-DMAC7.html)
DK (1) DK2699247T3 (cg-RX-API-DMAC7.html)
ES (1) ES2672693T3 (cg-RX-API-DMAC7.html)
PL (1) PL2699247T3 (cg-RX-API-DMAC7.html)
RU (2) RU2611396C2 (cg-RX-API-DMAC7.html)
TR (1) TR201808037T4 (cg-RX-API-DMAC7.html)
WO (1) WO2012145723A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2611396C2 (ru) * 2011-04-20 2017-02-21 Де Реджентс Оф Де Юниверсити Оф Калифорния Способ совместного кондиционирования и хемоселекции за один цикл
US9682106B2 (en) * 2011-04-20 2017-06-20 The Regents Of The University Of California Method for combined conditioning and chemoselection in a single cycle
US20170209447A1 (en) * 2014-08-07 2017-07-27 Nitor Therapeutics Use of PNP Inhibitor to Treat Relapse of Malignancy after Hematopoietic Stem Cell Transplant
US20180140606A1 (en) * 2016-11-18 2018-05-24 Calimmune, Inc. In Vivo Chemoselection with Low Dose Thioguanine
JP6783674B2 (ja) 2017-01-20 2020-11-11 株式会社日立ハイテク 自動分析装置、自動分析装置における廃液方法、及び、三方電磁弁
CA3070242A1 (en) * 2017-07-18 2019-01-24 Calimmune, Inc. Compositions and methods for treating beta-hemoglobinopathies
EP3654994B1 (en) * 2017-07-18 2022-12-28 CSL Behring Gene Therapy, Inc. A modulatable switch for selection of donor modified cells
WO2019074980A1 (en) * 2017-10-09 2019-04-18 Stowers Institute For Medical Research METHODS AND COMPOSITIONS FOR EXPANSION OF CELL POPULATION
EP3897831A1 (en) * 2018-12-23 2021-10-27 CSL Behring LLC Donor t-cells with kill switch
CN113518825A (zh) * 2018-12-23 2021-10-19 美国杰特贝林生物制品有限公司 Wiskott-aldrich综合征的造血干细胞基因疗法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5965126A (en) 1996-03-25 1999-10-12 The Penn State Research Foundation use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents
WO1997043900A1 (en) * 1996-05-24 1997-11-27 The President And Fellows Of Harvard College In vivo selection
AU7605796A (en) 1996-11-04 1998-05-29 Saint Jude Children's Research Hospital (in vivo) selection of primitive hematopoietic cells
DE69841058D1 (de) * 1997-11-14 2009-09-24 Gen Hospital Corp Behandlung von hämatologischen störungen
GB9904281D0 (en) * 1999-02-24 1999-04-21 Reneuron Ltd Transplantation
US7094885B2 (en) * 1999-07-11 2006-08-22 Neorx Corporation Skeletal-targeted radiation to treat bone-associated pathologies
US20030032003A1 (en) * 2000-02-02 2003-02-13 Schiestl Robert H. In vivo selection
WO2002040049A2 (en) * 2000-11-14 2002-05-23 The General Hospital Corporation Blockade of t cell migration into epithelial gvhd target tissues
US7037900B2 (en) * 2001-10-12 2006-05-02 Supergen, Inc. Composition and method for treating graft-versus-host disease
RU2611396C2 (ru) * 2011-04-20 2017-02-21 Де Реджентс Оф Де Юниверсити Оф Калифорния Способ совместного кондиционирования и хемоселекции за один цикл

Also Published As

Publication number Publication date
EP3384912B1 (en) 2020-11-11
JP2018044007A (ja) 2018-03-22
HK1256048A1 (en) 2019-09-13
AU2012245269B2 (en) 2016-09-29
ES2672693T3 (es) 2018-06-15
US9439928B2 (en) 2016-09-13
RU2017104621A (ru) 2018-08-15
TR201808037T4 (tr) 2018-06-21
AU2016259368A1 (en) 2016-12-08
RU2013151632A (ru) 2015-05-27
RU2611396C2 (ru) 2017-02-21
EP2699247A4 (en) 2014-11-19
JP6560332B2 (ja) 2019-08-14
AU2012245269A1 (en) 2013-12-05
EP2699247A1 (en) 2014-02-26
EP3799876A1 (en) 2021-04-07
AU2016259368B2 (en) 2017-12-14
EP3384912A1 (en) 2018-10-10
US20140154225A1 (en) 2014-06-05
JP5997257B2 (ja) 2016-09-28
EP2699247B1 (en) 2018-03-07
AU2018200967B2 (en) 2019-08-15
JP2014512391A (ja) 2014-05-22
DK2699247T3 (en) 2018-06-14
JP2019199476A (ja) 2019-11-21
JP2017008090A (ja) 2017-01-12
CA2861440A1 (en) 2012-10-26
CA2861440C (en) 2022-11-15
JP6799117B2 (ja) 2020-12-09
PL2699247T3 (pl) 2018-09-28
JP6266716B2 (ja) 2018-01-24
WO2012145723A1 (en) 2012-10-26
AU2018200967A1 (en) 2018-03-01
RU2728867C2 (ru) 2020-07-31

Similar Documents

Publication Publication Date Title
BR112013031251A2 (cg-RX-API-DMAC7.html)
BR112013027245A2 (cg-RX-API-DMAC7.html)
BR112013024383A2 (cg-RX-API-DMAC7.html)
BR112013026905A2 (cg-RX-API-DMAC7.html)
BR112013023185A2 (cg-RX-API-DMAC7.html)
BR112013022995A2 (cg-RX-API-DMAC7.html)
BR112013026744A2 (cg-RX-API-DMAC7.html)
AP3853A (cg-RX-API-DMAC7.html)
BR112013023927A2 (cg-RX-API-DMAC7.html)
BR112013027452A2 (cg-RX-API-DMAC7.html)
BR112013024365A2 (cg-RX-API-DMAC7.html)
BR112013028733A2 (cg-RX-API-DMAC7.html)
BR112013027121A2 (cg-RX-API-DMAC7.html)
AP2016009466A0 (cg-RX-API-DMAC7.html)
BR112013031556A2 (cg-RX-API-DMAC7.html)
BR112013032368A2 (cg-RX-API-DMAC7.html)
BR112013018949A2 (cg-RX-API-DMAC7.html)
BR112013032377A2 (cg-RX-API-DMAC7.html)
BR112013026895A2 (cg-RX-API-DMAC7.html)
BR112013027761A2 (cg-RX-API-DMAC7.html)
BR112013021637A2 (cg-RX-API-DMAC7.html)
BR112013025487A2 (cg-RX-API-DMAC7.html)
BR112013023266A2 (cg-RX-API-DMAC7.html)
BR112013030734A2 (cg-RX-API-DMAC7.html)
BR112013027112A2 (cg-RX-API-DMAC7.html)